(firstQuint)A Clinical Study of the Efficacy and Safety of MEBO Wound Ointment in Subjects With Partial Thickness Burns.

 MEBO-BPII-001 is a single-center, randomized, standard care-controlled pilot study of topically applied MEBO in subjects with partial thickness burns expected to heal in 14 days.

 Twice daily application of MEBO versus standard of care will be evaluated in a parallel design.

 Fourteen subjects will be randomized (7 subjects per treatment arm) to one of two treatment groups.

.

 A Clinical Study of the Efficacy and Safety of MEBO Wound Ointment in Subjects With Partial Thickness Burns@highlight

The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with partial thickness burns.

